Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Basel Medical Group Ltd Ordinary Shares
BMGL
NASDAQ·Healthcare·Medical - Healthcare Plans·Mkt cap $11.1M
$7.92
▲ +11.71%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$4.60 - $54.60
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 66.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Integrated healthcare platform offering end-to-end medical solutions
- Strong positioning in Singapore's developed healthcare market
- Diversified revenue streams across multiple healthcare segments
- Early-mover advantage as a newly incorporated healthcare provider with fresh operational frameworks
Bear Case
1 risk
- Low volatility (beta 0.2).
Growth
No forward estimates available
Rising healthcare spending in Southeast Asia and aging demographic trends
Value
Valuation data unavailable
Momentum
Stable
-0.7% over 3m
Quality
Loss-making
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying BMGL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Earnings recap unavailable for this period.
EPS surprise · last 4Q
No quarterly earnings data on file.
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
No analyst coverage on file for this stock yet.